Highridge Medical acquired multiple product lines from Accelus to strengthen its spine implant portfolio.
Westminster, Colorado-based Highridge — the spine company sold by ZimVie to H.I.G Capital in 2024, two years after ZimVie spun out of Zimmer Biomet — acquired the FlareHawk and Toro expandable interbody fusion systems and the LineSider pedicle screw system from Accelus.
Related: GE HealthCare launches new ultrasound system for cardiovascular imaging
FlareHawk features a minimal insertion profile and controlled in-situ, multiplanar expansion. Accelus designed it to restore foraminal height and sagittal balance while reducing subsidence and conforming to the patient’s endplates. Toro offers multidirectional expandable cage technology and novel instrumentation. LineSider delivers greater procedural visibility, versatility and efficiency, the company says.
The strategic acquisitions strengthen Highridge’s position in the expandable interbody space, the company said. It enables the integration of Accelus’ proprietary Adaptive Geometry implant designs into the Highridge portfolio. This can provide enhanced offerings for both hospitals and ambulatory surgery centers (ASCs).
Highridge said this deal marks another milestone as it doubles its investment in R&D through organic development and acquisitions.
“As we build out a compelling Highridge product portfolio and deepen our commitment to innovative minimally invasive lumbar spine solutions, we believe these Accelus products are a great strategic fit for our business,” said Rebecca Whitney, CEO of Highridge Medical. “This agreement puts the differentiated products Accelus has developed into the hands of our established and comprehensive sales force to serve a broader market, allowing us to bring a more robust portfolio of spine solutions to our current and future surgeon customers and the patients they serve.”
